Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2016 | Challenges associated with developing treatments for solid and rare tumors

Bruce Johnson • 3 Jun 2016
ASCO 2016
General

Bruce Johnson, MD, from Dana-Farber Cancer Institute, Boston, MA, discusses the challenges associated with developing effective treatments for patients with solid tumors. Prof Johnson discusses the efforts that are being made in terms of defining subgroups of patients and relevant therapy approaches for common tumors such as breast cancer, lung cancer and colon cancer. He also talks about how for unusual tumors, the challenge is to identify therapy targets and recruit sufficient numbers of patients for trials.
Recorded at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO).

More from Bruce Johnson

1:34
The rising cost of drugs and how to address it
Bruce Johnson • 3 Jun 2016
0:57
Transforming the care of patients with precision medicine
Bruce Johnson • 3 Jun 2016
0:59
The challenges Prof. Bruce Johnson will be faced with as the president of ASCO
Bruce Johnson • 3 Jun 2016

Related Videos

4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
1:41
The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals